A psychedelic experience may not be required to benefit from psilocybin
Recent research smooths the path toward at-home psilocybin treatment for neurological conditions
Low doses of magic mushrooms cause "enduring" decrease in migraines
A small double-blind study shows promising results
A new psychedelic drug gives psychiatric benefits without causing hallucinations
Research on ibogaine shows it is possible to engineer away side effects from beneficial psychoactives
Scientists identify a powerful anti-inflammatory compound in psychedelic drugs
The compound, called 2 C-H, reduces inflammation without mind-altering effects
Yeast could soon make psilocybin cheaper than their magic mushroom cousins can
New work could even lead to psychedelic intermediates not previously available in large quantities
How have mental disorders with hallucinations been treated in the past?
A brief history of treating mental illnesses
A brief history of psychedelic research, from LSD to psilocybin
A ban long stymied what started as a promising field
The psychedelic renaissance is here. Will it last this time?
To avoid the mistakes of the past, scientists and society need to open their minds